Published in N Engl J Med on December 08, 1988
The Vietnam Chloroquine Treatment on COVID-19 (VICO) | NCT04328493
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother (1997) 7.36
Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol (1992) 1.97
High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Am J Trop Med Hyg (2008) 1.72
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother (2007) 1.64
Validation of a chloroquine-induced cell death mechanism for clinical use against malaria. Cell Death Dis (2014) 1.46
Clinical and parasitological response to oral chloroquine and primaquine in uncomplicated human Plasmodium knowlesi infections. Malar J (2010) 1.29
Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization. Antimicrob Agents Chemother (2013) 1.21
Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial. J Infect Dis (2011) 1.13
Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clin Microbiol Rev (2004) 1.06
Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells. J Clin Invest (1998) 0.98
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria. Br J Clin Pharmacol (1995) 0.93
Management of relapsing Plasmodium vivax malaria. Expert Rev Anti Infect Ther (2016) 0.88
Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon. Mem Inst Oswaldo Cruz (2014) 0.80
Treatment of severe malaria. J R Soc Med (1989) 0.79
Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity. Cell Biochem Funct (2016) 0.75
Antiparasitic drugs in children. Clin Pharmacokinet (1989) 0.75
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (1991) 16.77
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Averting a malaria disaster. Lancet (1999) 9.40
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
Competitive Hebbian learning through spike-timing-dependent synaptic plasticity. Nat Neurosci (2000) 6.52
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet (1971) 6.05
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature (1998) 5.98
Etiology of human breast cancer: a review. J Natl Cancer Inst (1973) 5.88
The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug Alcohol Depend (1996) 5.35
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Halving of mortality of severe melioidosis by ceftazidime. Lancet (1989) 4.70
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
Influence of tobacco marketing and exposure to smokers on adolescent susceptibility to smoking. J Natl Cancer Inst (1995) 4.61
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J Cell Biol (1998) 4.52
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol (1990) 4.16
Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (1992) 3.93
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64
Neural mechanisms of orientation selectivity in the visual cortex. Annu Rev Neurosci (2000) 3.62
Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg (1994) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem (2000) 3.46
Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann Trop Med Parasitol (1978) 3.40
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health (1998) 3.38
A kaiC-interacting sensory histidine kinase, SasA, necessary to sustain robust circadian oscillation in cyanobacteria. Cell (2000) 3.31
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med (1977) 3.27
Autoimmune disease and parasitic infections in Nigerians. Lancet (1968) 3.22
Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiol (1988) 3.18
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation (2000) 3.12
Immunosuppression in children with malaria. Lancet (1972) 3.11
Adaptive licensing: taking the next step in the evolution of drug approval. Clin Pharmacol Ther (2012) 3.08
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. Bull World Health Organ (1997) 3.00
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83
The patient-centred clinical method. 2. Definition and application. Fam Pract (1986) 2.83
Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75
The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73
Childhood maltreatment increases risk for personality disorders during early adulthood. Arch Gen Psychiatry (1999) 2.73
Carriage of pneumococci after pneumococcal vaccination. Lancet (1996) 2.69
Placental malaria. I. Pathological classification. Histopathology (1993) 2.62
Allergic complications of meningococcal disease. II. Immunological investigations. Br Med J (1973) 2.61
Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 2.60
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol (1999) 2.59
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Cigarette smoking and urinary estrogens. N Engl J Med (1982) 2.55
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg (2001) 2.54
Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet (1989) 2.51
CikA, a bacteriophytochrome that resets the cyanobacterial circadian clock. Science (2000) 2.50
Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med (1997) 2.49
Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Paediatr (1987) 2.42
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41
Contrast-invariant orientation tuning in cat visual cortex: thalamocortical input tuning and correlation-based intracortical connectivity. J Neurosci (1998) 2.40
The limitations of verbal autopsy in a malaria-endemic region. Ann Trop Paediatr (1994) 2.40
Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children. Trans R Soc Trop Med Hyg (1988) 2.40
Treponemal infection and the outcome of pregnancy in a rural area of The Gambia, west Africa. J Infect Dis (1992) 2.39
Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39
Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol (1993) 2.38
Notch gene expression during pancreatic organogenesis. Mech Dev (2000) 2.36
MEK kinase activity is not necessary for Raf-1 function. EMBO J (2001) 2.36
Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol (2000) 2.35
Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol (2000) 2.34
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33
Addiction versus stages of change models in predicting smoking cessation. Addiction (1996) 2.29
Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. Bull World Health Organ (1997) 2.28
Complement and meningococcal infection. Br Med J (1976) 2.28
Evidence for a malaria mitogen in human malaria. Nature (1975) 2.25
Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet (2000) 2.24
Bacillus sphaericus strain 2362: identification and nucleotide sequence of the 41.9 kDa toxin gene. Nucleic Acids Res (1987) 2.24
Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis (1987) 2.23
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Identification, cloning and sequence analysis of the Bacillus sphaericus 1593 41.9 kD larvicidal toxin gene. Mol Microbiol (1987) 2.21
Physicians certified in family medicine. What are they doing 8 to 10 years later? Can Fam Physician (2001) 2.21
Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci (1985) 2.21
Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J Biol Chem (2001) 2.20
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Infection after total knee arthroplasty. J Bone Joint Surg Br (2004) 2.17
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol (1995) 2.16
Nanoliter scale PCR with TaqMan detection. Nucleic Acids Res (1997) 2.11
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11
Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry (1996) 2.10